Article

Gefitinib effectively treated advanced lung cancer with a rare EGFR L747P mutation in a kidney transplant recipient: the first case report

2023-11-30

Abstract excerpt

<title>Abstract</title> <p>Allograft kidney transplantation is considered to be the best treatment for end-stage renal disease, which can both improve the quality of life and prolong the life of patients. The inevitable use of immunosuppressants after kidney transplantation is highly associated with <italic>De Novo</italic> malignancies, which are currently the second cause of death among kidney transplant recipi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e3133045-47d0-53b5-b10e-81ef7add0dbb
DOI: 10.21203/rs.3.rs-3639777/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Gefitinib effectively treated advanced lung cancer with a rare EGFR L747P mutation in a kidney transplant recipient: the first case reportDOI 10.21203/rs.3.rs-3639777/v1Read

Afatinib treatment in a lung adenocarcinoma patient harboring a rare EGFR L747P mutation.Semantic proximity Read

EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.Semantic proximity Read

A rare EGFR mutation L747P conferred therapeutic efficacy to both geﬁtinib and osimertinib: A case report.Semantic proximity Read

Non-small cell lung cancer harboring a rare EGFR L747P mutation showing intrinsic resistance to both gefitinib and osimertinib (AZD9291): A case report.Semantic proximity Read

Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer.Semantic proximity Read

First-line gefitinib therapy for elderly patients with non-small cell lung cancer harboring EGFR mutation: Central Japan Lung Study Group 0901Semantic proximity Read

A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non-Small Cell Lung Cancer Patient.Semantic proximity Read

The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma—LetterSemantic proximity Read

Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation.Semantic proximity Read

Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutations.Semantic proximity Read

Good response to gefitinib in a lung adenocarcinoma harboring a heterozygous complex mutation of L833V and H835L in epidermal growth factor receptor gene.Semantic proximity Read

[Efficacy of gefitinib for young patients with unknown EGFR gene mutation in advanced lung adenocarcinoma].Semantic proximity Read